Celebrex 200mg capsule contains the active ingredient Celecoxib. It belongs to the family known as non-steroidal anti-inflammatory drugs (NSAID), and specifically a sub-group known as cyclooxygenase-2 (COX-2) inhibitors. It is used in adults for the relief of signs and symptoms of rheumatoid arthritis, osteoarthritis, and ankylosing spondylitis. In conditions like rheumatoid arthritis and osteoarthritis, excess production of prostaglandins by your body can lead to pain and inflammation. This medicine works by decreasing the production of prostaglandins, effectively reducing pain and inflammation.
Do not take Celebrex 200mg capsule if you are allergic to Celecoxib or any of its ingredients. Inform your doctor if you had reactions to sulfonamide medicines, suffer from ulcers or bleeding in the stomach or intestines, or experienced adverse reactions to NSAID medications like aspirin. Before starting the treatment, inform your doctor because it is recommended to not take this medicine if you are pregnant or are breastfeeding. Do not take this medicine if you have severe liver or kidney disease, have inflammatory intestinal conditions, or have heart-related issues such as heart failure, heart disease, or circulation problems. Additionally, if you have had surgeries on leg arteries or have a history of blood circulation problems, this medicine usage should be avoided. This contains lactose. If you are sugar intolerant, consult your doctor before using this product. This medicine is for adults only, it is not for use in children.
Inform your doctor about if you have a history of stomach or intestinal ulcers or bleeding (avoid if currently present), are on acetylsalicylic acid or antiplatelet therapies, use blood clotting or corticosteroid medications, or simultaneously use other non-acetylsalicylic NSAIDs like ibuprofen. Report your doctor if you have conditions such as smoking, diabetes, high blood pressure, high cholesterol, compromised heart, liver, or kidney function, fluid retention, dehydration, past severe allergic reactions to medications, ongoing infections, or are over 65 years old. Monitoring may be necessary. Notably, Celebrex 200mg capsule could mask fever or infection signs. Remember, alcohol combined with NSAIDs may increase gastrointestinal risks.
Celecoxib 200mgCelecoxib belongs to a class of drugs known as COX-2 inhibitors. It works by decreasing the production of the body’s pain and inflammation; thus, it reduces pain and swelling caused by different conditions. Celecoxib is used to treat:
Celebrex 200mg capsule contains the active ingredient, celecoxib. It is used to treat:
Celecoxib 200mg capsule is used to relieve signs and symptoms of rheumatoid arthritis and osteoarthritis such as:
The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser.For the best experience on our site, be sure to turn on Javascript in your browser.
Celebrex-200-MG-Oral-Capsule
Celecoxib is used to relieve pain and inflammation (swelling) caused by various conditions. It is also used to treat conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain. It is also used to reduce the risk of osteoarthritis and other forms of arthritis. See also Drug Information section. Celebrex-200 mg/4 tablets is a selective cyclooxygenase (COX-1) inhibitor. It also blocks the effect of prostaglandins, substances that cause pain and inflammation. See also Drug Information. See also Drug.
This medication may be available under multiple brand names, including Celebrex. For purposes of this medication article, a brand name is used used when two or more medicines are being taken the same way, such as by mouth. A brand name may also be used when a medicine brand is used to treat a specific condition; see also Drug.
This medication may also be sold as an oral capsule, capsule, or dosing tablet. An oral tablet may be used to take by mouth, with or without food. An oral solution may be used for swallowing. An oral suspension may be used for swallowing. It is also available in a convenient, pill-free dosage form. An alternative to oral pills, especially if you have difficulty swallowing pills, may be needed.
This document may not be complete, but the full deal is as below.Note:
This product is a controlled release product. The information provided below is provided through the U. S. Pharmacopeia, except as required for the information provided below, including any questions relating to it. No information is provided for public information purposes and it is not intended to substitute for, or for the advice of your physician or other health care provider.
Allergan, Inc.
(the "Princeton® company") is a global, leader in pharmaceuticals. Over 80 million people reside in United States and Canada and 160 million members of the European Pharmacopoeia (EP) work together to improve patient outcomes and reduce adverse drug reactions. The U. Pharmacopeia (U. Pharmacopeial Information, Volume 17, Page 437-450, December 2023, was updated on September 18, 2005 to provide a list of the nation's leading pharmaceutical companies. To view the updated U. Pharmacopeia Information, visit.
Novo Nordisk
North America holds the highest market share in the world for prescription medicines. Pharmacopeial Information, Volume 17, Page 439-440, December 2023, except on the Prescription Drug Information (U. Pharmacopeial Information) Information Service, U. Pharmacopeial Information, Volume 6, Page 437-450, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 8, Page 437-450, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 9, Page 437-450, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 10, Page 437-450, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 11, Page 439-440, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 12, Page 439-440, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 13, Page 439-440, December 2023, except on the Prescription Drug Information Service, U. Pharmacopeial Information, Volume 14, Page 439-440, December 2023, except on the Prescription Drug Information Service, U.
CELEBREX 200MG CAPSULE contains Celecoxib which belongs to group of medicines called Non-steroidal anti-inflammatory drugs. CELEBREX 200MG CAPSULE is used in adults to manage osteoarthritis (degenerative joint disease), rheumatoid arthritis (inflammatory disease of joints), ankylosing spondylitis (chronic back pain), acute pain and primary dysmenorrhea (menstrual cramps).
CELEBREX 200MG CAPSULE is also used to manage juvenile rheumatoid arthritis (in children aged 2 years and above).
CELEBREX 200MG CAPSULE is not recommended for use in patients allergic to Celecoxib, sulfonamides, aspirin and/or other NSAIDs. It is also not recommended for use in patients with/had a history of an ulcer in stomach/intestines, bleeding in stomach/intestines, blood circulation problems (such as peripheral arterial disease), red itchy welts, inflammatory disease of the intestines (such as ulcerative colitis/Crohn’s disease).
The medicine is also not indicted for use in patients suffering from lung problems (such as asthma), heart diseases (such as heart failure, recent heart attack, heart block), severe liver disease (such as advanced hepatic insufficiency) and/or kidney disease (such as advanced renal insufficiency).
Before taking CELEBREX 200MG CAPSULE, inform your doctor if you have diabetes, raised blood pressure, increased cholesterol, signs of fluid retention (such as swollen ankles and feet) and/or hyperkalemia (increased potassium level in blood).
CELEBREX 200MG CAPSULE is not recommended for use in pregnant and breast-feeding women.
CELEBREX 200MG CAPSULE should be used with caution in children and adolescents (aged 2 to 17 years) to manage only juvenile rheumatoid arthritis and is advised to be used with caution in elderly patients (aged 65 years/above) after consulting the doctor.
The most common side effects of taking CELEBREX 200MG CAPSULE are high blood pressure, shortness of breath, sore throat, cough, headache, nausea and dizziness. Consult your doctor if any of these symptoms worsen.
The brand name for CELEBREX 200MG CAPSULE is CELEBREX AB.The content on this page is you can trust this companyand we have all the necessary information for you.
When filling your prescription, you can buy CELEBREX AB online from our doctor. Our doctor also have doctor medical board service to get you a doctor medical board medicine doctor. We have all the necessary information for you.
The online prescription is a good option for CELEBREX AB. The doctor medical board is very user friendly.
CELEBREX 200MG CAPSULE is a medicine. It is an arthritis and pain medicine. It is an NSAID used for for juvenile rheumatoid arthritis and an NSAID used for an ankylosing spondylitis. It is also used for managing other pain and inflammation.
CELEBREX AB is an anti-inflammatory medicine used for treating juvenile rheumatoid arthritis and an ankylosing spondylitis. CELEBREX AB is a medicine used for managing other pain and inflammation. It is also used for the treatment of juvenile rheumatoid arthritis and an ankylosing spondylitis.
CELEBREX 200MG CAPSULE belongs to the group of medicines called non-steroidal anti-inflammatory drugs.
The FDA's announcement in June was followed by the launch of generic versions of the arthritis drug Celebrex. As part of the "Pfizer's approval" of Celebrex, Pfizer announced that it was "reviewing the potential risks and benefits of the drug" and will make a decision about the availability of the generic version on the market. Pfizer said that, "as with any new medication, the potential side effects and risks associated with the use of generic versions of Celebrex should be carefully weighed against the benefits and risks of the drug" (AP, March 26, 2010).
Pfizer had hoped that the generic version of Celebrex would have a long-term impact on its patients' lives. However, a study in theJournal of the American Medical Associationfound that over two million patients in the United States are prescribed the generic version of Celebrex (up from about 1 million in the 1990s) (Cantor, 2012). The study, "Oncology in Adults: Celebrex and Its Potential Adverse Reactions to Cancer Treatments," included an extensive review of clinical trials evaluating Celebrex in patients with advanced and metastatic colon cancer. The review examined more than 1,200 patients in trials of Celebrex. The study analyzed data from 7,400 patients, including 1,600 patients on the drug that had no known co-morbidities. The researchers looked at all trials involving Celebrex and other cancer drugs that had been shown to cause harm or adverse events. The study found that the incidence of side effects in the Celebrex group was "significantly lower than the rates reported with placebo-controlled trials in patients with metastatic colon cancer," while there was no difference with placebo. The rate of adverse events was similar in the Celebrex group and the placebo group (1.6% vs. 0.7%, p=0.9), with a similar incidence with other drugs. The Celebrex group also had fewer adverse events compared with the placebo group (0.1% vs. 0.1%, p=0.01).
The study's results were "significantly more severe" than what the FDA had expected in 2004 (Cantor, 2004). The company also had to consider a number of potential drug interactions that may affect Celebrex's safety and efficacy. The company said that, "The most important factor in the safety and efficacy of Celebrex is its pharmacokinetic profile, and the drug's ability to cross the blood-brain barrier and in the brain to exert its effect on certain neuroendocrine pathways in patients with metastatic colon cancer and other conditions that may predispose to cancer." The company also had to consider drug interactions that may affect Celebrex's safety and efficacy.
CVS Health'sDrugsnewsletter has more on Celebrex and other arthritis drugs in its ongoing newsletter.
Copyright 2013 Health, Inc. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
Stade de France Pharmacy